Eye inflammation clues could unlock new treatments for blinding disease
NCT ID NCT03418220
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study measured inflammation-related proteins in the eye fluid of 82 people with different stages of age-related macular degeneration (AMD) and a control group without AMD. The goal was to identify specific markers that might explain why some forms of AMD progress faster and to find targets for future treatments. Participants provided samples during cataract surgery, and the study did not involve any experimental therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION, AGE-RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital de la Croix-Rousse
Lyon, 69004, France
Conditions
Explore the condition pages connected to this study.